Belite Bio Statistics
Total Valuation
Belite Bio has a market cap or net worth of $6.24 billion. The enterprise value is $5.79 billion.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Belite Bio has 39.34 million shares outstanding. The number of shares has increased by 9.82% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 39.34M |
| Shares Change (YoY) | +9.82% |
| Shares Change (QoQ) | +9.01% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 10.59% |
| Float | 18.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 8.33 |
| P/TBV Ratio | 8.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 50.02, with a Debt / Equity ratio of 0.00.
| Current Ratio | 50.02 |
| Quick Ratio | 49.90 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42,104.00 |
Financial Efficiency
Return on equity (ROE) is -16.94% and return on invested capital (ROIC) is -11.48%.
| Return on Equity (ROE) | -16.94% |
| Return on Assets (ROA) | -11.29% |
| Return on Invested Capital (ROIC) | -11.48% |
| Return on Capital Employed (ROCE) | -10.93% |
| Weighted Average Cost of Capital (WACC) | -2.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.89M |
| Employee Count | 41 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +172.59% in the last 52 weeks. The beta is -1.22, so Belite Bio's price volatility has been lower than the market average.
| Beta (5Y) | -1.22 |
| 52-Week Price Change | +172.59% |
| 50-Day Moving Average | 168.90 |
| 200-Day Moving Average | 123.76 |
| Relative Strength Index (RSI) | 42.72 |
| Average Volume (20 Days) | 146,389 |
Short Selling Information
The latest short interest is 1.11 million, so 5.05% of the outstanding shares have been sold short.
| Short Interest | 1.11M |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 5.05% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -84.21M |
| Pretax Income | -77.61M |
| Net Income | -77.61M |
| EBITDA | -84.02M |
| EBIT | -84.21M |
| Earnings Per Share (EPS) | -$2.31 |
Full Income StatementBalance Sheet
The company has $492.42 million in cash and $429,000 in debt, giving a net cash position of $491.99 million or $12.51 per share.
| Cash & Cash Equivalents | 492.42M |
| Total Debt | 429,000 |
| Net Cash | 491.99M |
| Net Cash Per Share | $12.51 |
| Equity (Book Value) | 770.49M |
| Book Value Per Share | 19.59 |
| Working Capital | 484.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.99 million and capital expenditures -$178,000, giving a free cash flow of -$37.17 million.
| Operating Cash Flow | -36.99M |
| Capital Expenditures | -178,000 |
| Depreciation & Amortization | 184,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -37.17M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |